Skip to content
Governance Register

Company · London

Hikma Pharmaceuticals International Limited

Wholesale of pharmaceutical goods

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Hikma Pharmaceuticals International Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 17

  1. Nassim Rahmani 2022-2025 Director View profile
  2. Bana Khouri 2022-2025 Director View profile
  3. Joanna Elizabeth Hansen 2020-2025 Director View profile
  4. Gurpal Singh Atwal 2019-2022 Director View profile
  5. Dr Basel Ibrahim Bakir Awad 2017-2019 Director View profile
  6. Natheer Masarweh 2017-2019 Director View profile
  7. Michael Alex Raya 2016-2017 Director View profile
  8. Frank Louis Savastano 2016-2019 Director View profile
  9. Brian Scott Hoffmann 2016-2018 Director View profile
  10. Riad Mishlawi 2016-2019 Director View profile
  11. Jane Celia Hyde 2016-2016 Director View profile
  12. Thomas Michael Crease 2014-2015 Director View profile
  13. Abrehet Asfeha 2011-2014 Director View profile
  14. Tareq Mazen Samih Darwazah 2011-2014 Director View profile
  15. Maen Abdel-Hamid Abdullah Abdel-Hafez 2011-2014 Director View profile
  16. Peter Alexander Speirs 2011-2022 Director View profile
  17. Hussein Arkhaqa 2011-2014 Director View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

Public contracts won

3 contracts · £15,529,352 total

From Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.

  • NHS National Generic Pharmaceuticals - Wave 16a Buyer: NHS England £15,529,352 2026-08-27 Source: Find a Tender

    NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…

    Framework
  • Transitional Drugs 7 Buyer: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) Value not published Date not published Source: Find a Tender

    The provision of Drugs that have recently lost exclusivity

  • NHS National Generics Pharmaceuticals - Supply Chain Resilience Buyer: NHS England Value not published Date not published Source: Find a Tender

    NHS National Generics Pharmaceuticals - Supply Chain Resilience Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months…

    Framework

About

What it does
Wholesale of pharmaceutical goods
Incorporated
23/06/2011
Registered office
London
Previous names
West-Ward Pharmaceuticals International Limited (until 19/10/2018)
West-Ward (GB) Limited (until 14/09/2011)

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Hikma Pharmaceuticals International Limited is controlled by Hikma UK Limited
    Evidence
    active 75-100% shares · notified 2016-05-25 · source: Companies House PSC register
  2. Hikma UK Limited is controlled by Hikma Pharmaceuticals Public Limited Company
    Evidence
    active 75-100% shares, 75-100% voting · notified 2021-01-04 · source: Companies House PSC register

Ultimately controlled by Hikma Pharmaceuticals Public Limited Company.

5 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

3 directors on the board

3.1y median 3.9y
average tenure
4y
longest tenure
0
directors past 6 years

First-time vs portfolio directors

First-time (1)

Portfolio (2)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Manufacturing 2Finance 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
07680243
Status
Active
Type
Private Limited Company
Accounts next due
30/09/2027
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data